The Witcher 4 has now been officially revealed, with a new trailer confirming that the game will focus on Ciri as the main protagonist. This latest look does give us an idea as to the overall ...

Needless to say, these phones look premium and to make them look stand out, Samsung packs the Galaxy S-series phones with gorgeous-looking wallpapers. The newly launched Galaxy S25 series continues ...

We advise you to avoid simply saving the image previews you see below. These wallpaper previews are compressed and optimized for improved website performance. Instead, you should click the button ...

For comparison, the researchers reviewed data on 2.4 million patients who use other types of diabetes treatments. It is the largest study ever of the drug category—which includes Novo Nordisk ...

Short interest in Novo Nordisk declined greatly in December, falling 17.3% to 4.7 million shares. This translates to a low days-to-cover ratio of 0.8, suggesting limited short-selling pressure.

Lone Star Funds is selecting advisers to explore a possible sale or initial public offering of Portuguese lender Novo Banco SA, according to people familiar with the matter. The private equity ...

Despite the company’s enthusiasm, questions remain about how Novo's latest numbers can move the needle in a competitive market. The company's stock price decline of 4% on Friday seems to ...

Medicare’s next drug price negotiations will treat Novo Nordisk’s semaglutide as a single product, regardless of whether the metabolic disease medicine is used to treat diabetes or heart risk, and ...

Jan 16 (Reuters) - Novo Holdings, the controlling shareholder ... Catalent, which had sales of $4.38 billion in 2024, will hold its next board meeting in February, according to Levy.

Novo Nordisk presents a compelling 'Strong Buy ... According to Seeking Alpha, there are 4.44 billion shares outstanding. The fair share price estimate is $127.62, which is way higher compared ...

In a press release this morning, Eli Lilly was pleased to announce that 2024 revenues are tracking about $4 billion above what ... why not only Eli Lilly but Novo Nordisk and Viking Therapeutics ...